list : Precision Health

  • Possible drug target for cardiomyopathy

    Stanford researchers have uncovered how a genetic mutation contributes to a heart disease known as familial dilated cardiomyopathy. Existing drugs correct the defect in heart cells grown in a petri dish, suggesting a new therapeutic target.

  • Dynamic predictions help patients

    Using in-game win probability techniques, Stanford researchers devised a way to better predict a cancer patient’s outcome at any point during treatment. The approach could also inform treatment decisions.

  • Big data, the patient and the provider

    Invisible sensors, machine learning for disease diagnoses, big data in the clinic and more took the stage as topics at this year’s Big Data in Precision Health Conference.

  • Pilot program for precision health

    A Stanford clinical trial that provided proactive, personalized care to participants detected overlooked health conditions and risks.

  • Revealing health through big data

    Years-long tracking of individuals’ biology helped define what it meant for them to be healthy and showed how changes from the norm could signal disease, a Stanford-led study reports.

  • Identifying familial hypercholesterolemia

    Stanford scientists and their collaborators have devised an algorithm to predict the risk of a disease that, untreated, can lead to heart attack or stroke.

  • Brain networks predict PTSD treatment success

    Clinicians may be able to determine whether people with post-traumatic stress disorder will respond to psychotherapy by analyzing a key brain network and memory, according to Stanford researchers.

  • Immune cell-based cancer diagnostics

    Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.

  • Apple Heart Study demonstrates ability of wearable technology to detect atrial fibrillation

    Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.

  • Discovery could limit toxic effect of chemo

    Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.